Suppr超能文献

大鼠血浆中的激肽释放酶抑制剂。

Kallikrein inhibitors in rat plasma.

作者信息

Hojima Y, Isobe M, Moriya H

出版信息

J Biochem. 1977 Jan;81(1):37-46. doi: 10.1093/oxfordjournals.jbchem.a131448.

Abstract

The kallikrein inhibitor contents of human and animal plasma were determined with glandular kallikreins [EC 3.4.21.8]. One ml of plasma could inactivate 20-700 kallikrein units (KU). Rat plasma was the most potent and inactivated 230-700 KU. However, no enzyme capable of inactivating kallikrein could be found in this plasma. Two fractions which inhibited hog pancreatic kallikrein, a fraction corresponding to alpha2-macroglobulin and a fraction which was eluted prior to albumin, were separated from rat plasma by Sephadex G-200 gel filtration. The former inhibitor could inhibit hog pancreatic kallikrein action on Nalpha-benzoyl-L-arginine ethyl ester (BAEE) as well as in the dog vasodilator assay. The other inhibitor was partially purified from rat plasma. One mg of the preparation inhibited 67 KU and the hydrolysis of 5.8 micronmoles/min of BAEE by hog pancreatic kallikrein [EC 3.4.21.8]. The inhibitor also inhibited other glandular and plasma kallikreins, trypsin [EC 3.4.21.4], alpha-chymotrypsin [EC 3.4.21.1], etc. The optimal pH of the inhibitor was 7.5-8. The inhibitor was unstable below pH 5, and was destroyed by heating at temperature above 60 degrees. The isoelectric point of the inhibitor was determined by Ampholine focusing to be 4.4, and its molecular weight was estimated to be 73,000 by Sephadex G-100 and G-150 filtrations. Several experimental results suggested that this inhibitor differed from alpha1-antitrypsin.

摘要

用腺体激肽释放酶[EC 3.4.21.8]测定了人和动物血浆中的激肽释放酶抑制剂含量。1毫升血浆可使20 - 700个激肽释放酶单位(KU)失活。大鼠血浆的活性最强,可使230 - 700 KU失活。然而,在这种血浆中未发现能够使激肽释放酶失活的酶。通过Sephadex G - 200凝胶过滤从大鼠血浆中分离出两种抑制猪胰激肽释放酶的组分,一种对应于α2 - 巨球蛋白的组分,另一种在白蛋白之前洗脱的组分。前一种抑制剂可抑制猪胰激肽释放酶对Nα - 苯甲酰 - L - 精氨酸乙酯(BAEE)的作用以及在犬血管舒张试验中的作用。另一种抑制剂从大鼠血浆中部分纯化。1毫克该制剂可抑制67 KU以及猪胰激肽释放酶[EC 3.4.21.8]每分钟对5.8微摩尔BAEE的水解。该抑制剂还抑制其他腺体和血浆激肽释放酶、胰蛋白酶[EC 3.4.21.4]、α - 糜蛋白酶[EC 3.4.21.1]等。该抑制剂的最佳pH值为7.5 - 8。该抑制剂在pH值低于5时不稳定,在60度以上加热会被破坏。通过两性电解质聚焦测定该抑制剂的等电点为4.4,通过Sephadex G - 100和G - 150过滤估计其分子量为73,000。几个实验结果表明该抑制剂不同于α1 - 抗胰蛋白酶。

相似文献

1
Kallikrein inhibitors in rat plasma.
J Biochem. 1977 Jan;81(1):37-46. doi: 10.1093/oxfordjournals.jbchem.a131448.
2
Purification of cat submaxillary kallikrein.
J Biochem. 1979 Feb;85(2):549-57. doi: 10.1093/oxfordjournals.jbchem.a132363.
3
Dog renal kallikrein: purification and some properties.
J Biochem. 1976 Dec;80(6):1277-85. doi: 10.1093/oxfordjournals.jbchem.a131399.
4
Purification and properties of rat stomach kallikrein.
Biochim Biophys Acta. 1980 Aug 7;614(2):501-10. doi: 10.1016/0005-2744(80)90239-9.
5
Purification of kallikrein from cat submaxillary gland.
Adv Exp Med Biol. 1976;70(00):151-6. doi: 10.1007/978-1-4684-3267-1_19.
6
Studies on urinary kallikreins. I. Purification and characterization of human urinary kallikreins.
J Biochem. 1976 Oct;80(4):671-9. doi: 10.1093/oxfordjournals.jbchem.a131326.
8
A kallikrein-specific inhibitor in rat kidney tubules.
Hoppe Seylers Z Physiol Chem. 1976 Apr;357(4):553-8. doi: 10.1515/bchm2.1976.357.1.553.

引用本文的文献

1
Isolation and properties of a new kallikrein inhibitor from Tityus serrulatus venom.
J Protein Chem. 1998 Nov;17(8):799-805. doi: 10.1023/a:1020778302161.
2
A tissue kallikrein in the synovial fluid of patients with rheumatoid arthritis.
Ann Rheum Dis. 1989 Feb;48(2):128-33. doi: 10.1136/ard.48.2.128.
3
[Renal kallikrein-kinin system and control of blood pressure (author's transl)].
Klin Wochenschr. 1979 Oct 1;57(19):1037-45. doi: 10.1007/BF01479989.
4
The renal kallikrein-kinin system in human and in experimental hypertension.
Klin Wochenschr. 1978;56 Suppl 1:113-25. doi: 10.1007/BF01477462.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验